Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2019-11-24 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
首次公开发行股票并在科创板上市网下初步配售结果及网上中签结果公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial public offering (IPO) of Wuxi Xiangsheng Medical Technology Co., Ltd., including the offline preliminary allotment results and online lottery results for the stock issuance on the STAR Market (科创板). It contains detailed information about the share allocation, subscription results, allotment procedures, and payment instructions. The document is not a financial report, earnings release, or management discussion, but rather an official announcement of the results of a share issuance and subscription process. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes such as IPO allotment results.
2019-11-24 Chinese
首次公开发行股票并在科创板上市网上发行申购情况及中签率公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the initial public offering (IPO) of Wuxi Xiangsheng Medical Technology Co., Ltd., detailing the subscription situation for the online issuance and the lottery results for allotment. It includes information about the number of shares issued, pricing, subscription rates, allotment mechanisms, and payment obligations. The document does not contain financial statements or detailed financial performance data but rather provides procedural and subscription outcome information related to the IPO. It is not a full financial report, earnings release, or management discussion. The document is also relatively short (3640 characters) and serves as an official announcement of subscription results and allotment rates. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-11-21 Chinese
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司首次公开发行股票并在科创板上市之战略配售事项之专项核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed special verification opinion from Guojin Securities Co., Ltd. regarding the strategic placement matters of Wuxi Xiangsheng Medical Technology Co., Ltd.'s initial public offering (IPO) and listing on the STAR Market. It references specific regulatory rules and guidelines related to securities issuance and underwriting, strategic investor selection, and compliance with prohibitive conditions. The document focuses on the verification of strategic investor qualifications, shareholding structure, and compliance with regulatory requirements for the IPO process. It does not contain financial statements, earnings data, or management discussion of financial results. It is not an announcement of voting results, nor a general regulatory filing or a report publication announcement. The content is a specialized verification opinion related to capital issuance and strategic placement in an IPO context, which aligns best with a Capital/Financing Update (CAP) filing type, as it deals with fundraising and capital structure changes through the IPO and strategic placement process. The document length is under 5,000 characters but contains substantive content rather than a mere announcement or certification, so it is not RPA or RNS. Therefore, the most appropriate classification is CAP with high confidence.
2019-11-19 Chinese
上海市锦天城律师事务所关于无锡祥生医疗科技股份有限公司首次公开发行股票并在科创板上市战略投资者核查事项的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the verification of strategic investors for a company's initial public offering (IPO) and listing on the STAR Market (科创板). It discusses the legal compliance and qualifications of the strategic investor involved in the IPO process. The document is not a financial report, earnings release, or management discussion. It is a standalone legal opinion related to the IPO process, which fits the category of a legal proceedings report or legal opinion related to regulatory compliance. Given the content and nature, it best fits the category 'Legal Proceedings Report (LTR)'. The document length is about 5,000 characters, and it contains substantive legal analysis rather than just an announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2019-11-19 Chinese
首次公开发行股票并在科创板上市发行公告
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding the initial public offering (IPO) of Wuxi Xiangsheng Medical Technology Co., Ltd. It includes extensive information about the stock issuance, pricing, investor subscription procedures, regulatory approvals, underwriting, and allocation mechanisms. The text references regulatory bodies such as the China Securities Regulatory Commission and Shanghai Stock Exchange, and discusses the offering price, investor categories, subscription dates, and allotment rules. The document is not a financial report, earnings release, or management discussion, but rather a comprehensive issuance announcement for a company's first public stock offering. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes such as IPOs.
2019-11-19 Chinese
首次公开发行股票并在科创板上市投资风险特别公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "首次公开发行股票并在科创板上市投资风险特别公告" which translates to "Initial Public Offering and Listing on the STAR Market Investment Risk Special Announcement." It details the IPO process, pricing, allocation, subscription procedures, risk factors, and regulatory approvals related to the company's first public stock issuance and listing on the Shanghai Stock Exchange STAR Market. The document is issued by the company and its sponsor under regulatory oversight. It is not a financial report like an Annual Report or Interim Report, nor is it a transcript, audit report, or management report. It is a detailed announcement about the IPO issuance and associated investment risks, including pricing and subscription details. This fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPOs. The document length (7330 characters) and content confirm it is a substantive announcement, not a brief notice or a report publication announcement.
2019-11-19 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.